Tolterodine tartrate is a medication used to treat overactive bladder symptoms like frequent urination, urgency, and urge incontinence. It belongs to the class of drugs called antimuscarinics or muscarinic receptor antagonists that work by reducing bladder contractions and relaxing the smooth muscles of the urinary tract.
Chemical name: The chemical name of tolterodine tartrate is (R)-2-[3-[bis(1-methylethyl)amino]-1-phenylpropyl]-4-methylphenol L-(+)-tartrate.
Molecular formula: The molecular formula of tolterodine tartrate is C22H31NO.C4H6O6.
Formula weight: The molecular weight of tolterodine tartrate is 475.6 g/mol.
CAS No: The CAS number of tolterodine tartrate is 124937-52-6.
Top ten keywords from Google and synonyms:
Synonyms: • (R)-2-[3-[Bis(1-methylethyl)amino]-1-phenylpropyl]-4-methylphenol tartrate (1:1) • Tolterodine l-tartrate • PNU-200583E Tartrate • Anoctamin-1 Inhibitor
Health benefits of this product: Tolterodine tartrate helps manage overactive bladder symptoms and reduces the frequency of urination, urgency, and urge incontinence. By blocking the muscarinic receptors located in the detrusor muscle and other parts of the urinary tract, tolterodine tartrate prevents involuntary contraction of the bladder, thereby improving bladder control.
Potential effects: Tolterodine tartrate may cause dry mouth, constipation, blurred vision, abdominal pain, and urinary retention. In rare cases, it may lead to confusion, hallucinations, and memory problems. Tolterodine tartrate can also interact with certain medications, causing adverse effects or reducing their efficacy. Patients should inform their healthcare provider about all the prescription and non-prescription medications they are taking before starting tolterodine tartrate.
Product mechanism: Tolterodine tartrate works by preventing the binding of acetylcholine to the muscarinic receptors present in the bladder and urinary tract. This prevents involuntary contractions of the detrusor muscle, which contracts the bladder during urination. By relaxing the smooth muscles of the urinary tract, tolterodine tartrate reduces urinary urgency and frequency.
Safety: Tolterodine tartrate is generally safe when taken as prescribed by a healthcare professional. However, patients with a history of liver or kidney disease, glaucoma, myasthenia gravis, or gastric retention should avoid using tolterodine tartrate. Pregnant or breastfeeding women should also avoid tolterodine tartrate unless prescribed by a healthcare professional.
Side effects: The most common side effects of tolterodine tartrate include dry mouth, constipation, blurred vision, abdominal pain, and urinary retention. In rare cases, it may lead to confusion, hallucinations, and memory problems.
Dosing information: The recommended dose of tolterodine tartrate is 2 mg twice daily, with or without food. The maximum daily dose should not exceed 4 mg. For patients with severe liver or kidney dysfunction, the initial dose should be 1 mg twice daily.
Conclusion: Tolterodine tartrate is an effective medication for managing overactive bladder symptoms like frequency of urination, urgency, and urge incontinence. It works by blocking the muscarinic receptors present in the bladder and urinary tract, preventing involuntary contractions of the detrusor muscle. Although generally safe, tolterodine tartrate may cause adverse effects like dry mouth, constipation, blurred vision, and abdominal pain. Patients should inform their healthcare provider about all the prescription and non-prescription medications they are taking before starting tolterodine tartrate.
